Everett, WA (PRWEB) March 4, 2005
A merger and/or acquisition of a company can be a good thing or not such a good thing depending on who you are talking with. Hospitals now faced with added cost, delays in product delivery, lost savings, product quality and patient safety, are forced to accept the acquisition of a Pacific Northwest medical device reprocessing vendor.
ÂReNu Medical and Hospital Shared Services Association (HSSA) will help hospitals by filling the gap left by this acquisition. Hospitals desiring to continue with the advantages of high-level disinfection, reducing their medical waste and double the savings over sterilization, all at a price equal to or less than their previous vendor is available right now through HSSA,Â said Loren Timmons, VP of Marketing and Business Development for ReNu Medical.
HSSA is a non-profit organization of member facilities voluntarily joined together on a unified basis for the purpose of reducing the cost of health care delivery by the most effective use of our combined market power. Hospital Shared Services Association is a regional cooperative consisting of a network of hospitals and health services throughout the Pacific Northwest. Their members share the common goals of reducing costs while maintaining the highest level of patient care.
ÂHospitals originally made the right choice to have non and semi critical single use devices high-level disinfected. We are very excited to be partnering with HSSA to bring our service, price and quality products to their members. ReNu and HSSA can provide a cost effective solution to escalating healthcare costs,Â said L. Bruce Pierson, COO at ReNu Medical.
About Renu Medical:
ReNu Medical is the leading reprocessor of non-invasive single use medical devices (SUDÂs). ReNuÂs unique services focus on providing the safest product for the patient, reducing medical waste and significantly reducing supply costs by maximizing available savings.
ReNuÂs unique focus on non and semi critical devices provides a significant source of cost savings with very little associate risk. These devices go ON the body not IN the body. High Level Disinfection (HLD) offers significant cost saving advantages over sterilization methods.
For example, ReNuÂs non-toxic method of HLD has the proven ability to turn an individual medical device 2-3 times more than a sterilizing reprocessor which equates to 2-3 times the cost savings. Additionally, with our quick turn around time, two weeks compared to 8-12 weeks, less inventory is required thus saving you even more money. Finally, ReNu has the proven lowest discard rate in the industry (less than 10% on average) allowing you to get more devices back. These advantages offer significant savings far above other reprocessors.
High-Level Disinfection technology is 100% non toxic, environmentally friendly and a safe gentle alternative for the non and semi critical devices. HLD offers twice the life span and double the saving of toxic Ethylene Oxide Gas (EtO) utilized by sterilization reprocessorÂs. No harmful air emissions are released into the environment and no chemical residue is left on the device. HLD is supported by the CDC, APIC, and other healthcare organizations.
ReNu Medical is a supporter and Champion of Hospitals for a Healthy Environment. We recommend you visit their website (http://www.h2e-online.org) to learn more about how to reduce hospital medical waste.
# # #